Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01944462 · ClinicalTrials.gov registry record · Phase 4
Impact and Cost of a Pharmacist Pneumococcal Vaccination Program With PNEUMOVAX® 23 at an Urban Senior Center
A Phase 4 study, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- Phase 4
- Development phase
- 203
- Enrollment target
NCT01944462 is a Phase 4 study that has completed, run by Thomas Jefferson University. The registered enrollment target is 203 participants.
The verdict
NCT01944462, a Phase 4 study, has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 203 participants
- Enrollment target
Study Summary
The overall goals of this program are to measure the impact of a pharmacist pneumococcal vaccine education program (PPVP) using a senior center model of care and provide the pneumococcal vaccine to eligible participants. Hypotheses 1. PPVP will result in improved knowledge and awareness in older minorities in the senior center setting (primary hypothesis); 2. Participants who are vaccinated through the project will experienced increased trust in receiving vaccines from a pharmacist; 3. Participants will be satisfied with and trust the PV information provided by pharmacists in the PPVP; 4. PPVP is an efficient approach to educating patients in the senior center based on its costs; 5. Participating pharmacists will be activated to implement PPVP learnings in their practice.
Interventions
- BEHAVIORAL Pharmacist Pneumococcal Vaccine Program (PPVP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 203 participants |
| Start Date | 2014-01 |
| Est. Completion | 2014-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01944462
The ClinicalTrials.gov registry entry for NCT01944462 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 203 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pharmacist Pneumococcal Vaccine Program (PPVP) is the first listed.
NCT01944462 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01944462 about?
NCT01944462 is a clinical study titled "Impact and Cost of a Pharmacist Pneumococcal Vaccination Program With PNEUMOVAX® 23 at an Urban Senior Center". The overall goals of this program are to measure the impact of a pharmacist pneumococcal vaccine education program (PPVP) using a senior center model of care and provide the pneumococcal vaccine to eligible participants. Hypotheses 1. PPVP will result in improved knowledge and awareness in older m...
What is the current status of trial NCT01944462?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 203 participants. The study started on 2014-01. Estimated completion is 2014-11.
What interventions are being tested in trial NCT01944462?
The interventions under investigation include: Pharmacist Pneumococcal Vaccine Program (PPVP) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01944462?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.